Cytotoxicity and subcellular localization of boronated phenanthridinium analogues

Anti-Cancer Drug Design

Volumn 12, Issue 8, 1997, Pages 671-685

  Gedda, Lars ^a   Silvander, Mats ^a   Sjöberg, Stefan ^a   Tjarks, Werner ^a   Carlsson, Jörgen ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; ANTINEOPLASTIC AGENT; BORON DERIVATIVE; DNA; PHENANTHRIDINE DERIVATIVE;

ARTICLE; CELL DEATH; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BINDING; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG DNA BINDING; DRUG STRUCTURE; FLUORESCENCE ANALYSIS; GLIOMA CELL; HUMAN; PRIORITY JOURNAL;

BORON; BORON COMPOUNDS; CELL NUCLEUS; CELL-FREE SYSTEM; CYTOPLASM; DNA, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; GLIOMA; HUMANS; PHENANTHRIDINES; TUMOR CELLS, CULTURED;

EID: 0031454371     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. ARGENTINI, M , DOS SANTOS, D., WEINREICH, R. & HANSEN, H. (1994). Chemical synthesis of a dodecaborane derivative of Hoechst 33258 for BNCT. In Hardrontherapy in Oncology. Amaldi, U. & Larsson, B. (eds), p. 555. Elsevier Science: Amsterdam.
2. BENEDIKTSSON, G., BLOMQUIST, E. & CARLSSON, J (1990). Failure of betamethasone to alter the radiation response of two cultured human glioma cell-lines. Journal of Neurooncology, 8, 47.
3. BIGNER, S H., BURGER, P.C., WONG, A.J., WERNER, M.H., HAMILTON, S.R., MUHLBAIER, L.H., VOGELSTEIN, B. & BIGNER, D.D. (1988). Gene amplification in malignant human gliomas: clinical and histopathologic aspects. Journal of Neuropathology and Experimental Neurology, 47, 191.
4. CAPALA, J , BARTH, R.F., BENDAYAN, M , LAUZON, M., ADAMS, D.M., SOLOWAY, A.H., FENSTERMAKER, R A. & CARLSSON, J. (1996). Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors. Bioconjugate Chemistry, 7, 7.
5. COLLINS, V.P. &. JAMES, C.D. (1993). Gene and chromosomal alterations associated with the development of human gliomas. Faseb Journal, 7, 926.
6. 10B-labelled DNA ligand. In Advances in Neutron Capture Therapy. Soloway, A., Barth, R. & Carpenter, D. (eds), p. 377. Plenum Press: New York.
7. CRISTIANO, R J & ROTH, J.A (1996). Epidermal growth factor mediated DNA delivery into lung cancer cells via the epidermal growth factor receptor. Cancer Gene Therapy, 3, 4.
8. 7Li reaction in cells and tissue and its implication for boron neutron capture therapy. Radiation Research, 111, 14.
9. GEDDA, L., OLSSON, P. & CARLSSON, J. (1996a). Preparation of epidermal growth factor conjugates aimed for boron neutron capture therapy. In Cancer Neutron Capture Therapy. Mishima, Y (ed.), p. 37. Plenum Press: New York.
10. GEDDA, L., OLSSON, P., PONTÉN, J. & CARLSSON, J. (1996b). Development and in vitro studies of epidermal growth factor-dextran conjugates for boron neutron capture therapy. Bioconjugate Chemistry, 7, 584.
11. HARIHARAN, J., WYZLIC, I. & SOLOWAY, A. (1995). Synthesis of novel boron-containing polyamines - agents for DNA targeting in neutron capture therapy. Polyhedron, 14, 823.
12. HARTMAN, T. & CARLSSON, J. (1994). Radiation dose heterogeneity in receptor and antigen mediated boron neutron capture therapy. Radiotherapy and Oncology, 31, 61.
13. JOHANSSON, L., NILSSON, K., CARLSSON, J., LARSSON, B. & JAKOBSSON, P. (1981). Radiation effects on cultured human lymphoid cells. Analysis using the growth extrapolation method. Acta Radiologia Oncologia, 20, 51.
14. JOHANSSON, L., CARLSSON, J. & NILSSON, K. (1983). Radiation sensitivity of human histiocytic lymphomas in vitro. Acta Radiologia Oncologia, 22, 315.
15. KELLY, D., BATEMAN, S., MARTIN, R., REUM, M., ROSE, M. & WHITTACKER, A. (1994). DNA binding compounds. V. Synthesis and characterization of boron-containing bibenzimidazoles related to the DNA minor groove binder, Hoechst 33258. Australian Journal of Chemistry, 47, 247.
16. KOBAYASHI, T. & KANDA, K. (1982). Analytical calculation of boron-10 dosage in cell nucleus for neutron capture therapy. Radiation Research, 91, 77.
17. LE PECQ, J.B. & PAOLETTI, C. (1966). A new fluorometric method for RNA and DNA determination. Analytical Biochemistry, 17, 100.
18. LIBERMANN, T.A., RAZON, N , BARTAL, A.D., YARDEN, Y., SCHLESSINGER, J. & SOREQ, H. (1984). Expression of epidermal growth factor receptors in human brain tumors. Cancer Research, 44, 753.
19. LINDSTRÖM, P., OLSSON, P., MALMQVIST, J., PETTERSSON, J , LEMMEN, P., WERNER, B., SJÖBERG, S., OLIN, A. & CARLSSON, J. (1994). New carborane-based compounds for boron neutron capture therapy: binding and toxicity of ANC-1, DAC-1 and B-Et-11-OMe in cultured human glioma and mouse melanoma cells. Anticancer Drugs, 5, 43.
20. NGUYEN, T., BROWNELL, G.L., HOLDEN, S.A., KAHL, S., MIURA, M. & TEICHER, B.A. (1993). Subcellular distribution of various boron compounds and implications for their efficacy in boron neutron capture therapy by Monte Carlo simulations. Radiation Research, 133, 33.
21. NISTÉR, M., LIBERMANN, T.A., BETSHOLTZ, C., PETTERSSON, M , CLAESSON WELSH, L., HELDIN, C.H., SCHLESSINGER, J. & WESTERMARK, B. (1988). Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines. Cancer Research, 48, 3910.
22. PONTÉN, J. & WESTERMARK, B. (1978). Properties of human malignant glioma cells in vitro. Medicinal Biology, 56, 184.
23. SHARMA, R.P. & EDWARDS, I R. (1983). cis-Platinum: subcellular distribution and binding to cytosolic ligands. Biochemical Pharmacology, 32, 2665.
24. SILVANDER, M. & EDWARDS, K. (1996). A method to detect leakage of DNA intercalators through liposome membranes. Analytical Biochemistry, 242, 40.
25. SJÖBERG, S., CARLSSON, J., GHANEOLHOSSEINI, H., GEDDA, L., HARTMAN, T., MALMQUIST, J., NAESLUND, C., OLSSON, P. & TJARKS, W. (1997). Chemistry and biology of some low molecular weight boron compounds for boron neutron capture therapy. Journal of Neurooncology, 33, 41.
26. SJÖSTRÖM, A., BUE, P., MALMSTRÖM, P.-U , NILSSON, S. & CARLSSON, J. (1997). Binding, internalization and degradation of EGF-dextran conjugates in two human bladder-cancer cell lines. International Journal of Cancer, 70, 383.
27. SOLOWAY, A. (1964). Boron compounds in cancer therapy. In Progress in Boron Chemistry. McCloskey, A. & Steinberg, H. (eds), Vol. I, p. 203. Pergamon Press: New York.
28. TAS, J & WESTERNENG, G. (1981). Fundamental aspects of the interaction of propidium diiodide with nuclei acids studied in a model system of polyacrylamide films. Journal of Histochemistry and Cytochemistry, 29, 929.
29. TILLY, N , OLSSON, P., HARTMAN, T., CODERRE, J., MAKAR, M., MALMQUIST, J., SJÖBERG, S , PETTERSSON, J., CARLSSON, J. & GLIMELIUS, B. (1996). In vitro determination of toxicity, binding, retention, subcellular distribution and biological efficacy of the boron neutron capture agent DAC-1. Radiotherapy and Oncology, 38, 41.
30. TJARKS, W., GHANEOLHOSSEINI, H., HENSSEN, C.L.A., MALMQUIST, J. & SJÖBERG, S. (1996a). Synthesis of para-and nido-carboranyl phenanthridinium compounds for neutron capture therapy. Tetrahedron Letters, 37, 6905.
31. TJARKS, W., MALMQUIST, J , GEDDA, L., SJÖBERG, S. & CARLSSON, J. (1996b). Synthesis and initial biological evaluation of carborane-containing phenanthridinium derivatives. In Neutron Capture Therapy for Human Cancer. Mishima, Y. (ed.), p. 121. Plenum Press: New York.
32. YAMAMOTO, Y., CAI, J., NAKAMURA, H., SADAYORI, N., ASAO, N. & NEMOTO, H. (1995). Synthesis of netropsin and distamycin analogues bearing o-carborane and their DNA recognition. Journal of Organic Chemistry, 60, 3352.